• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Bangladesh Medical Research Council bulletin

    Bangladesh Medical Research Council bulletin

    JournalISSN 0377-9238eISSN 2224-7238

    年发文量

    研究主题

    论文(1052)

    排序
    1Geriatric Medicine Issues and Challenges for Implementation: A Perspective Bangladesh
    Aminur Rahman, Farhana Salam

    The aging population is a worldwide issue. The global population is aging. Due to the swiftly aging populace, geriatric medicine is an essential and growing sector with significant potential in Bangladesh. The main perspectives emphasize major shortcomings of the existing healthcare system, along with increasing acknowledgment and legislative efforts to address the specific needs of older adults. Geriatricians can significantly influence the shift in elder care towards a unified, individual-centered approach that emphasizes age-friendly services, preventive strategies, and functional abilities. A reliable, competency-based definition of a geriatrician needs to be established to effectively evaluate the existing workforce with the essential geriatric expertise to facilitate the paradigm shift. Geriatric medicine in Bangladesh is an essential and swiftly expanding area with significant possibilities because of the nation's aging demographic. The main perspectives underscore major difficulties in the existing healthcare system, along with increased focus and government initiatives to address the specific requirements of the elderly. Geriatricians can significantly contribute to redirecting the care of older individuals toward a cohesive and person-focused approach that emphasizes functional ability, preventive measures, and services tailored to their age. The present circumstances require initiatives to establish a coherent competency-focused outline of a geriatrician to effectively evaluate the current workforce, where adequate geriatric training acts as essential resources to support the transformation. This review aims to address challenges in implementing geriatric care in Bangladesh. Bangladesh Medical Res Counc Bull 2026;52(1): 63-70

    2026
    引用
    AI阅读
    加入学术空间
    2Therapeutic Outcomes of Tofacitinib with Dose Escalation Strategies in Patients with NSAID-Refractory Axial Spondyloarthritis
    Asadul Islam,Md Nahiduzzamane Shazzad, Rumana Fatme, Prayush Sharma, Muhammad Shaoib Momen Majumder, Mohammad Jahangir Ul Alam, Md Nazibur Rahman, Shamim Ahmed,Syed Atiqul Haq

    Background: Axial spondyloarthritis (axSpA) is often resistant to first-line non-steroidal anti-inflammatory drugs (NSAIDs), necessitating the use of advanced therapies. Janus kinase (JAK) inhibitors have become highly effective oral alternatives to biological agents. In resource-limited settings like Bangladesh, the availability of lower-cost tofacitinib provides a crucial therapeutic option, reducing financial and accessibility barriers associated with biologics. Effective patient management in these contexts requires tailored dosing strategies to carefully balance efficacy, safety, and affordability. Objective: To assess the therapeutic efficacy and safety of tofacitinib in patients with NSAID-refractory axSpA, with a particular focus on the outcomes of a dose-escalation strategy for patients showing an inadequate response to standard dosing. Methods: This prospective clinical trial (NCT03738956) enrolled 52 patients with NSAID-refractory axSpA. All participants initially received tofacitinib 5 mg twice daily (Phase A, months 0–3). At the end of month 3, treatment response was evaluated: patients achieving a clinically important improvement in ASDAS-CRP (“ASDAS-CRP e” 1.1) were maintained on 5 mg twice daily for the remainder of the study (Phase B, months 3–6). For those who failed to achieve this threshold, the tofacitinib dose was escalated to 10 mg twice daily. The primary efficacy endpoint was the ASAS20 response rate. Secondary assessments, conducted at baseline, 1, 3, and 6 months, included ASAS40/70, BASDAI, BASFI, ASDAS, MASES, CRP, ESR, spinal pain, and fatigue. Adverse events (AEs) and serious adverse events (SAEs) were actively monitored. Statistical significance was determined using two-sided tests, with p < 0.05 considered significant. Results: In this study, 52 patients (mean age 32.9 years, 78.8% male) were included. Tofacitinib demonstrated rapid and sustained efficacy; by month 3, overall ASAS20, ASAS40, and ASAS70 response rates were 73.1%, 65.4%, and 30.8%, respectively. Patients maintained on 5 mg twice daily (n=42) showed continued significant improvement at month 6 (ASAS20: 95.2%; ASAS40: 88.1%; ASAS70: 50.0%; all p<0.05). Ten patients (19.2%) with inadequate response at month 3 underwent dose escalation to 10 mg twice daily, achieving modest subsequent improvements by month 6 (ASAS20: 30%; ASAS40: 30%; ASAS70: 20%). All composite disease measures (including BASDAI, BASFI, and ASDAS-CRP) improved significantly from baseline (p<0.05). Adverse events occurred in 63.5% of patients, with serious adverse events, including herpes zoster and tuberculosis, reported in 13.5%. Conclusions: Standard dosing of tofacitinib showed rapid response, high efficacy, and sustained disease control in NSAID-refractory axial spondyloarthritis. Those with a poor response to the standard dose may benefit from dose escalation, but caution is required as serious adverse events are relatively common. Clinicians should prioritise vigilant safety monitoring and carefully weigh the risks and benefits before increasing the dose in non-responders. Bangladesh Medical Res Counc Bull 2026;52(1): 4-12

    2026
    引用
    AI阅读
    加入学术空间
    3Precision Medicine: the Promise and the Paradox
    Kazi Saifuddin Bennoor, Manal Mizanur Rahman

    The practice of Clinical Medicine is a dynamically evolving paradigm. In its earliest era, medicine was intuitive – doctors relied on “experience” and heuristic assessment of signs and symptoms rather than scientific evidence.1 Since the late 20th century, this has rightly been replaced by evidence-based medicine (EBM), with clinical trials and meta-analyses considered the height of empirical evidence. EBM has undoubtedly transformed population-level patient outcomes by fostering “best medical practices” supported by systematic medical research. Nonetheless, this system has an inherent limitation evidence-based guidelines are formulated from mean results from a relatively homogeneous trial population, with the deliberate exclusion of heterogeneous characteristics.2 Consequently, at the individual level in real-world settings, this often leads to heterogeneous outcomes such as poor responses or adverse events. This is due to inter-individual variation in genetics, lifestyle, environmental exposures, comorbidities or drug interactions.3 It has become increasingly evident that treatment should be personalized, i.e.,it should target the patient with the disease, rather than the disease in the patient. Bangladesh Medical Res Counc Bull 2026;52(1): 1-3

    2026
    引用
    AI阅读
    加入学术空间
    4Solitary Subungual Neurofibroma of the Right Great Toe: A Case Report
    Chowdhury Rashedul Mughni, Nusrat Jahan Mahin, Chowdhury Ali Adnan, Farah Imrana

    Background: Solitary subungual neurofibroma is an exceptionally rare benign tumor of the nerve sheath that most commonly presents as a slow-growing, painless subungual nodule. Owing to its uncommon location and nonspecific presentation, it is frequently misdiagnosed as a fungal or inflammatory nail disorder. With fewer than ten cases have been documented globally, making awareness and ensuring accurate diagnosis are essential. Case presentation: We report a case of a 47-year-old Bangladeshi male with a three-year history of a painless, progressively enlarging nodule beneath the nail of his right great toe. Clinical evaluation revealed nail deformity (onychodystrophy), lifting of the nail plate, and a firm mass beneath the nail, with no evidence of neurofibromatosis or any underlying systemic illness. Imaging and ultrasonography revealed a hypoechoic mass, and surgical excision under local anesthesia was performed. Histopathological analysis revealed a benign, unencapsulated spindle cell neoplasm with a shredded carrot collagenous appearance containing mast cells. Postoperative recovery was uneventful, with no recurrence after one year. Conclusion: This case highlights the diagnostic challenges posed by solitary subungual neurofibromas because of their rarity and nonspecific presentation. Early recognition, histopathological confirmation, and complete surgical excision are key to favorable outcomes. Clinicians should keep neurofibroma in mind as a possible diagnosis for nail bed tumors, particularly when imaging results are unclear. Bangladesh Medical Res Counc Bull 2026;52(1): 71-75

    2026
    引用
    AI阅读
    加入学术空间
    5Burden and Antimicrobial Resistance Pattern of Multidrug- Resistant Acinetobacter Baumannii in Burn Patients at a Tertiary Care Hospital in Dhaka
    Jannatul Ferdous Mustary, Kazi Imran Ahmed, Raisa Enayet Badhan, Shaila Akhtar

    Background: Acinetobacter species, particularly Acinetobacter baumannii, are among the most prevalent Gram negative pathogens responsible for hospital-acquired infections worldwide. These infections are widespread in Intensive Care Units (ICUs) and burn wards. Due to the organism’s ability to survive on surfaces for extended periods; its eradication from healthcare environments remains a significant challenge. In recent years, the alarming rise in antibiotic resistance among A. baumannii strains has become a major global health concern. Objectives: To explore the burden and antimicrobial resistance patterns of Multidrug-resistant (MDR) Acinetobacter baumannii isolates among burn patients admitted to a tertiary care burn hospital in Dhaka city. Method: This cross-sectional study was carried out on 200 samples over six months in the Department of Microbiology at the National Institute of Burn and Plastic Surgery, Dhaka, Bangladesh. Wound swab specimens were obtained from burn patients from the Intensive Care Unit (ICU) and High Dependency Unit (HDU) and general burn wards. Acinetobacter baumannii isolates were identified by conventional culture and biochemical methods. Antimicrobial susceptibility was done using the conventional disc diffusion method as well as the VITEK® 2 automated system due to the high burden of MDR organisms. Antimicrobial susceptibility testing was conducted in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines-2025. Tigecycline was used, as most of the isolates were MDR pathogens. Based on predefined criteria, the isolates were categorized as MDR organisms. Results: A total of 200 Acinetobacter spp. isolates were analyzed. The majority of patients were aged under 20 and the mean age was 23.3 ± 21.1 years, with a male-to-female ratio of 1.1:1. Overall, 98.5% of the isolates were classified as MDR, whereas only 1.5% were non-MDR. Resistance to cephalosporins and fluoroquinolones was markedly high. Carbapenem resistance to meropenem and imipenem was also high. Similarly, high resistance rates were observed for aminoglycosides, including gentamicin and amikacin. Relatively better susceptibility was noted for minocycline, tigecycline, colistin, and cefoperazone-sulbactam. The majority of susceptible isolates were MDR. Universal resistance to co-trimoxazole was observed. Overall, the findings demonstrate a high burden of multidrug resistance among Acinetobacter spp., with limited therapeutic options remaining effective. Conclusion: The study reveals a high burden of MDR Acinetobacter spp. in burn patients, with limited sensitivity to most antibiotics. The findings highlight the urgent need for antimicrobial stewardship and strict infection control in burn units. Bangladesh Medical Res Counc Bull 2026;52(1): 13-22

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1052 篇论文

    高被引作者

    作者引用发文
    Hajera Mahtab44510
    Syed Atiqul Haq39014
    K M Rahman33513
    Kishwar Azad3257
    Mohammed Abu Sayeed3167
    Pa Khanam2705
    Z A Latif2536
    Kazi Mejbaul Islam24410
    A. Banu2444
    Nazmul Islam23711

    高产作者

    作者引用发文
    Munira Jahan12220
    Syed Atiqul Haq39014
    K M Rahman33513
    Mehriban Amatullah611
    Shahina Tabassum10511
    Nazmul Islam23711
    Shah Md. Mahfuzur Rahman7111
    Md Ridwanur Rahman16610
    Hajera Mahtab44510
    Kazi Mejbaul Islam24410

    相关期刊

    Przeglad epidemiologiczny
    International Journal of Medical Research and Health Sciences
    Journal of Dhaka Medical College
    Journal of Dr. NTR University of Health Sciences
    Research Journal of Health Sciences
    CHRISMED Journal of Health and Research
    Chattagram Maa-O-Shishu Hospital Medical College Journal
    Pakistan Journal of Public Health
    Asian Journal of Medicine and Health
    Journal of Nature and Science of Medicine